Serotonin–norepinephrine releasing agent
![](http://upload.wikimedia.org/wikipedia/commons/thumb/3/3e/MBDB.svg/200px-MBDB.svg.png)
MBDB, an SNRA.
![](http://upload.wikimedia.org/wikipedia/commons/thumb/6/6e/Norfenfluramine.png/200px-Norfenfluramine.png)
Norfenfluramine, an SNRA.
A serotonin–norepinephrine releasing agent (SNRA) is a type of drug which induces the release of serotonin and norepinephrine (and epinephrine) in the body and/or brain.
Only a few SNRAs are known, examples of which include norfenfluramine and MBDB. Fenfluramine/phentermine (Fen-Phen), a combination formulation of fenfluramine, a serotonin releasing agent, and phentermine, a norepinephrine releasing agent, is a functional SNRA that was formerly used as an appetite suppressant for the treatment of obesity.
A closely related type of drug is a serotonin–norepinephrine reuptake inhibitor (SNRI).
See also[]
- Monoamine releasing agent
- Serotonin releasing agent
- Norepinephrine releasing agent
- Serotonin–dopamine releasing agent
- Serotonin–norepinephrine–dopamine releasing agent
References[]
Categories:
- Serotonin-norepinephrine releasing agents
- TAAR1 agonists
- VMAT inhibitors
- Pharmacology stubs